AML or CML dendritic cells (DC) for the in vitro generation of leukemia-reactive cytotoxic T cells.

被引：0
|
作者：
Brouwer, RE [1 ]
Bongaerts, R [1 ]
Van der Hoorn, MAWG [1 ]
Willemze, R [1 ]
Falkenburg, JHF [1 ]
机构：
[1] Leiden Univ, Med Ctr, Dept Hematol, Leiden, Netherlands
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
752
引用
收藏
页码：175A / 175A
页数：1
相关论文
共 50 条
  • [31] Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells.
    Avigan, DE
    Gong, JLG
    Wu, ZK
    Chen, DS
    Kashiwaba, M
    Koido, S
    Kufe, D
    BLOOD, 1999, 94 (10) : 679A - 679A
  • [32] In vitro system for generation of leukemia-specific cytotoxic T cells for adoptive immunotherapy.
    Ghosh, A
    Wolenski, M
    Klein, C
    Welte, K
    Blazar, BR
    Sauer, MG
    BLOOD, 2005, 106 (11) : 310A - 310A
  • [33] Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias
    Charbonnier, A
    Gaugler, B
    Sainty, D
    Lafage-Pochitaloff, M
    Olive, D
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1999, 29 (08) : 2567 - 2578
  • [34] In vitro differentiation of Langerhans and dendritic cells.
    Herbst, B
    Köhler, G
    Mackensen, A
    Lindemann, A
    BONE MARROW TRANSPLANTATION, 1998, 21 : S119 - S119
  • [35] Alloreactive and leukemia-reactive T cells are preferentially derived from naive precursors in healthy donors: implications for immunotherapy with memory T cells
    Distler, Eva
    Bloetz, Andrea
    Albrecht, Jana
    Asdufan, Saliha
    Hohberger, Alexander
    Frey, Michaela
    Schnuerer, Elke
    Thomas, Simone
    Theobald, Matthias
    Hartwig, Udo F.
    Herr, Wolfgang
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (07): : 1024 - 1032
  • [36] Dendritic cells (DC) generated from AML blasts express leukemia associated antigens eliciting specific cytotoxic T cell responses in the autologous host after DC vaccination.
    Li, L
    Reinhardt, P
    Hus, I
    Rolinski, J
    Dmoszynska, A
    Wiesneth, M
    Dohner, H
    Schmitt, M
    BLOOD, 2004, 104 (11) : 502A - 502A
  • [37] Cytotoxic T-lymphocyte harnessing CML66 can kill human myeloid leukemia cells, in vitro
    Suemori, Koichiro
    Fujiwara, Hiroshi
    Ochi, Toshiki
    Yasukawa, Masaki
    BLOOD, 2007, 110 (11) : 807A - 807A
  • [38] GENERATION OF LEUKEMIA-REACTIVE CYTOTOXIC LYMPHOCYTE-T CLONES FROM THE HLA-IDENTICAL BONE-MARROW DONOR OF A PATIENT WITH LEUKEMIA
    FABER, LM
    VANLUXEMBURGHEIJS, SAP
    WILLEMZE, R
    FALKENBURG, JHF
    JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05): : 1283 - 1289
  • [39] CML patient in hematologic remission can mount a cytotoxic T cell response in vitro against the natural peptides eluted from his CML cells.
    Buzyn, A
    Ostankovitch, M
    Kemula, M
    Connan, F
    Audat, F
    Varet, B
    Guillet, JG
    Choppin, J
    BLOOD, 1997, 90 (10) : 3985 - 3985
  • [40] CML patient in hematologic remission can mount a cytotoxic T cell response in vitro against the natural peptides eluted from his CML cells.
    Buzyn, A
    Kemula, M
    Connan, F
    Audat, F
    Varet, B
    Choppin, J
    Guillet, JG
    Ostankovitch, M
    BONE MARROW TRANSPLANTATION, 1998, 21 : S65 - S65
12345